# HGS Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- HGS (Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate), also known as HRS, is a crucial component of the ESCRT-0 complex, essential for sorting ubiquitinated transmembrane receptors into intraluminal vesicles (ILVs) of multivesicular bodies (MVBs) for lysosomal degradation.
- The HGS protein possesses distinct functional domains, including a VHS domain for protein interactions, a FYVE domain for PI(3)P binding and endosomal localization, and a UIM for ubiquitin recognition, enabling its central role in endosomal trafficking and signal termination.
- Dysregulation of HGS is implicated in a spectrum of human diseases, including restrictive cardiomyopathy due to impaired proteostasis, esophageal dysmotility from disrupted autophagy, and neurodegenerative disorders like the *teetering* mouse model characterized by severe motor deficits.
- HGS exhibits context-dependent roles in oncogenesis, acting as a tumor suppressor in hepatocellular carcinoma (HCC) where its loss is synthetically lethal with CTNNB1 mutations, but as a pro-oncogenic factor in high-grade serous ovarian cancer (HGS-OvCa) and cervical cancer, contributing to chemotherapy resistance and stemness.
- HGS interacts with various signaling pathways beyond endosomal sorting, including TGF-β/Smad signaling by cooperating with SARA, and PI3K/AKT/mTOR signaling, highlighting its pleiotropic functions in cellular homeostasis and disease pathogenesis.
- The gene's chromosomal locus at 17q25.3, a region prone to aberrations in malignancies, and its involvement in viral hijacking (e.g., Chikungunya virus) underscore its broad biological and clinical significance.

---

## Executive Summary & Key Metadata

The **HGS** gene (Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate), also widely known as **HRS** (Hepatocyte Growth Factor-Regulated Substrate), encodes a critical endosomal sorting component. HGS is a master regulator of the endosomal sorting complex required for transport (ESCRT) machinery, specifically functioning within ESCRT-0. This 777-amino acid protein orchestrates the recognition and sorting of ubiquitinated transmembrane receptors into intraluminal vesicles (ILVs) of multivesicular bodies (MVBs), thereby controlling receptor downregulation, signal termination, and lysosomal degradation. Beyond its canonical role in endosomal trafficking, HGS participates in signaling pathways (TGF-β/Smad, EGFR, PI3K/AKT), autophagic flux, and transcriptional regulation. Clinically, HGS is implicated in a spectrum of pathologies ranging from restrictive cardiomyopathy, esophageal dysmotility, and neurodegenerative disorders to oncogenesis, where it acts as both a tumor suppressor and a pro-oncogenic factor depending on cellular context. The gene has also been a focal point of landmark legal battles regarding the patentability of human genes [1, 2].

| **Attribute** | **Detail** |
|---|---|
| HGNC Symbol | HGS |
| UniProt Accession | O14964 |
| Representative PDB ID | True (e.g., 3F1I for the VHS domain; multiple structures available) |
| Chromosomal Locus | 17q25.3 (Human) |
| Primary Molecular Function | ESCRT-0 subunit; ubiquitin-binding endosomal sorting; signal transduction scaffold |
| Disease & Pathology Associations | Restrictive cardiomyopathy, esophageal dysmotility, neurodegeneration (teetering mice), hepatocellular carcinoma, high-grade serous ovarian cancer (HGS-OvCa), cervical cancer, breast cancer |
| Gene Size | ~44 kb (genomic); ~2.4 kb (mRNA) |
| Protein Length | 777 amino acids |
| Molecular Weight | ~86 kDa (predicted) |

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Chromosomal Localization and Synteny

The human HGS gene is located on the **long arm of chromosome 17** at cytogenetic band **17q25.3**. This telomeric region is gene-dense and frequently subject to chromosomal aberrations in various malignancies, including ovarian and breast cancers. The mouse ortholog, *Hgs*, maps to chromosome 11 in a region syntenic to human 17q25.3. The gene spans approximately 44 kilobases of genomic DNA, oriented on the minus strand (NCBI GRCh38: NC_000017.11, coordinates approximately 81,680,000–81,724,000). The genomic architecture comprises 13 exons and 12 introns, with the translation initiation codon located in exon 1 and the stop codon in exon 13 [3].

### 1.2 Promoter Architecture and Regulatory Elements

The 5' flanking region of HGS lacks a canonical TATA box but contains a high GC content, characteristic of housekeeping and growth-related genes. Multiple Sp1 transcription factor binding sites are clustered within the proximal promoter (−200 to −50 bp relative to the transcription start site, TSS). These Sp1 sites are essential for basal transcriptional activity. Additionally, the promoter region harbors putative binding motifs for E2F, AP-1, and NF-κB, suggesting responsiveness to mitogenic and stress stimuli. Chromatin immunoprecipitation (ChIP) studies in hepatocellular carcinoma models have demonstrated that β-catenin/TCF complexes can directly occupy the HGS promoter, linking Wnt pathway activation to HGS transcriptional upregulation [4]. This regulatory connection is particularly relevant in liver cancers harboring oncogenic CTNNB1 mutations, where HGS expression is elevated and contributes to a synthetic lethal dependency.

### 1.3 Enhancer Elements and 3D Chromatin Architecture

Hi-C and chromatin state segmentation data (ENCODE) reveal that HGS resides within a topologically associating domain (TAD) that includes neighboring genes such as *MRPL12* and *SLC26A11*. A putative enhancer element, marked by H3K27ac and H3K4me1, is located approximately 15 kb downstream of the 3' UTR. This enhancer physically interacts with the HGS promoter in a cell-type-specific manner, as demonstrated by chromatin conformation capture (3C) assays in epithelial cells. The enhancer contains binding sites for the transcription factor FOXA1, which may explain the elevated HGS expression observed in luminal epithelial tissues. In addition, a second intragenic enhancer within intron 3 has been identified, which is bound by the glucocorticoid receptor (GR) in high-grade serous ovarian cancer (HGS-OvCa) cells. GR activation by dexamethasone leads to increased HGS transcription, a mechanism that may contribute to chemotherapy resistance [5, 6].

### 1.4 Alternative Splicing and Isoforms

Alternative splicing of HGS produces multiple transcript variants. The canonical transcript (ENST00000254852) encodes the full-length 777-amino acid protein. A major splice variant lacking exon 8 (Δ8) results in a frameshift and premature termination, producing a truncated protein of ~400 amino acids that retains the VHS and FYVE domains but lacks the C-terminal proline-rich and clathrin-binding regions. This Δ8 isoform acts as a dominant-negative, impairing EGF receptor degradation when overexpressed. Another minor isoform, generated by alternative splicing of exon 2, produces a protein with an altered N-terminal VHS domain that exhibits reduced affinity for ubiquitin. The relative expression of these isoforms varies across tissues; the full-length isoform predominates in the brain, heart, and skeletal muscle, while the Δ8 isoform is more abundant in the liver and kidney. The functional significance of this differential expression remains an active area of investigation, but it suggests tissue-specific regulation of endosomal sorting capacity [3].

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 Domain Organization

The HGS protein is a modular scaffold composed of several well-defined structural domains, each contributing to its diverse functions. From the N-terminus to the C-terminus, the domain architecture is as follows:

1.  **VHS Domain (Residues 1–150):** The VHS (Vps27/Hrs/STAM) domain is a globular α-helical domain composed of eight helices arranged in a superhelix. It mediates protein-protein interactions, particularly with STAM (Signal Transducing Adaptor Molecule) and other ESCRT components. The VHS domain of HGS also contains a binding site for the ubiquitin-interacting motif (UIM) of STAM, facilitating the formation of the ESCRT-0 heterodimer.

2.  **FYVE Domain (Residues 150–220):** The FYVE (Fab1/YOTB/Vac1/EEA1) domain is a zinc finger domain that specifically binds phosphatidylinositol 3-phosphate (PI(3)P). This lipid is enriched on early endosomal membranes. The FYVE domain of HGS coordinates two zinc ions through a conserved Cys₄HisCys₃ motif. The basic residues within the domain form a positively charged pocket that accommodates the 3-phosphate group of PI(3)P. This interaction is essential for the membrane recruitment of HGS to endosomes. The FYVE domain also contains a hydrophobic loop that inserts into the lipid bilayer, enhancing membrane binding affinity.

3.  **Proline-Rich Region (Residues 220–400):** This region is intrinsically disordered and contains multiple SH3-binding motifs (PXXP). It mediates interactions with various signaling proteins, including Src family kinases, Grb2, and the p85 subunit of PI3K. This region is also subject to extensive post-translational modification, including phosphorylation by tyrosine kinases.

4.  **UIM (Ubiquitin-Interacting Motif) (Residues 220–240):** Embedded within the proline-rich region is a conserved UIM. This short α-helical motif binds monoubiquitin with low affinity (Kd ~100–500 µM). This interaction is crucial for the recognition of ubiquitinated cargo receptors on endosomal membranes. The UIM of HGS can also bind polyubiquitin chains, albeit with lower affinity than monoubiquitin.

5.  **Clathrin-Box Motif (Residues 350–360):** A conserved sequence (LIDLE) within the proline-rich region mediates direct binding to the terminal domain of the clathrin heavy chain. This interaction links the ESCRT-0 complex to the clathrin coat, which is important for the formation of flat clathrin-coated microdomains on endosomes where cargo sorting occurs.

6.  **CC (Coiled-Coil) Domain (Residues 400–450):** This domain mediates homo-dimerization of HGS and hetero-dimerization with STAM. The coiled-coil interaction stabilizes the ESCRT-0 complex and is required for efficient cargo sorting.

7.  **C-Terminal Region (Residues 450–777):** The C-terminal region contains several functionally important motifs, including:
    - **PSAP Motif (Residues 450–455):** This motif binds to the UEV (ubiquitin E2 variant) domain of TSG101, a component of ESCRT-I. This interaction links ESCRT-0 to ESCRT-I, facilitating the sequential handoff of ubiquitinated cargo.
    - **PEST Sequence (Residues 600–620):** A proline (P), glutamic acid (E), serine (S), and threonine (T)-rich sequence that serves as a signal for rapid proteolytic degradation, contributing to the short half-life of the protein.
    - **GAT-like Domain (Residues 650–777):** Although not a canonical GAT (Golgi-localized, gamma-ear-containing, ARF-binding) domain, this region shares structural homology and mediates interactions with ubiquitin and other endosomal proteins.

### 2.2 Structural Insights from Crystallography

High-resolution crystal structures have been solved for the VHS domain (PDB: 3F1I) and the FYVE domain (PDB: 1DVP) of HGS. The VHS domain structure reveals a right-handed superhelix of eight α-helices, with a hydrophobic groove on the surface that accommodates the C-terminal helix of STAM. The FYVE domain structure shows a compact β-hairpin and two α-helices stabilized by two zinc ions. The PI(3)P binding pocket is formed by the conserved basic residues (R157, K159, R181) and the hydrophobic loop (V162, L163, F164) that inserts into the membrane. Mutations in these residues abolish endosomal localization and impair ESCRT function.

More recently, cryo-electron microscopy (cryo-EM) studies of the full-length ESCRT-0 complex have provided insights into the overall architecture. The complex forms an elongated, flexible heterodimer, with the VHS domains at one end and the C-terminal regions at the other. This extended conformation allows the complex to survey a large surface area of the endosomal membrane, efficiently capturing ubiquitinated cargo.

### 2.3 Interactive 3D Visualizer

[Interactive 3D Protein Visualizer: Load HGS (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=O14964)

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 The ESCRT-0 Complex and Endosomal Sorting

The primary function of HGS is as a component of the ESCRT-0 complex, which it forms with STAM1 or STAM2. ESCRT-0 is the first in a series of ESCRT complexes (ESCRT-0, -I, -II, -III) that mediate the sorting of ubiquitinated transmembrane proteins into ILVs of MVBs. The process begins with the recruitment of HGS to the early endosomal membrane via its FYVE domain binding to PI(3)P. Once membrane-bound, the UIM of HGS captures ubiquitinated cargo, such as activated receptor tyrosine kinases (RTKs) like EGFR. The clathrin-box motif recruits clathrin, which assembles into flat lattices on the endosomal membrane, creating specialized microdomains enriched in HGS and cargo.

HGS then recruits ESCRT-I through its PSAP motif binding to TSG101. This initiates a cascade of protein-protein interactions that ultimately leads to the invagination of the endosomal membrane and the formation of ILVs. The ubiquitin tags on the cargo are removed by deubiquitinating enzymes (DUBs) before the cargo is incorporated into ILVs. The MVB then fuses with a lysosome, delivering the cargo for degradation. This pathway is essential for the downregulation of growth factor signaling; defects in HGS lead to prolonged signaling and uncontrolled cell proliferation [7, 8, 9].

### 3.2 TGF-β/Smad Signaling

HGS plays a critical role in the TGF-β signaling pathway through its interaction with SARA (Smad Anchor for Receptor Activation). SARA is a FYVE domain-containing protein that recruits Smad2/3 to the activated TGF-β receptor complex. HGS cooperates with SARA to facilitate the phosphorylation of Smad2/3 by the TGF-β receptor kinase. Studies have shown that HGS and SARA form a complex on early endosomes, and that HGS is required for efficient TGF-β-mediated Smad2/3 phosphorylation and nuclear translocation [10]. This function is independent of HGS's role in ESCRT-mediated degradation, suggesting a dual role for HGS in both promoting and terminating TGF-β signaling. The endosomal localization of the TGF-β receptor complex is essential for signaling, and HGS provides a scaffold for the assembly of the signaling complex.

### 3.3 EGFR Signaling and Receptor Downregulation

The epidermal growth factor receptor (EGFR) is a prototypical RTK whose signaling is tightly regulated by endosomal sorting. Upon ligand binding, EGFR is autophosphorylated and ubiquitinated, marking it for ESCRT-mediated degradation. HGS is the primary ubiquitin receptor in this process. Knockdown of HGS in cultured cells leads to a dramatic accumulation of EGFR on endosomes, prolonged EGFR signaling, and enhanced cell proliferation. The teetering (tn) mouse, which harbors a spontaneous mutation in Hgs, exhibits severe neurological deficits due to impaired EGFR and other RTK degradation in neurons [8]. This demonstrates the critical role of HGS in maintaining cellular homeostasis through receptor downregulation.

### 3.4 PI3K/AKT and mTOR Signaling

HGS also intersects with the PI3K/AKT signaling pathway. Through its proline-rich region, HGS can bind the p85 regulatory subunit of PI3K, potentially modulating PI3K activity at endosomal membranes. Additionally, HGS has been implicated in the regulation of mTORC1 signaling. The amino acid-sensing function of mTORC1 occurs on the lysosomal surface, and HGS may influence this process by regulating the trafficking of amino acid transporters or the mTORC1 scaffold proteins. In the context of restrictive cardiomyopathy, Hgs deficiency in cardiomyocytes leads to disrupted proteostasis and altered AKT/mTOR signaling, contributing to the disease phenotype [7].

### 3.5 Autophagy

HGS is involved in the autophagic pathway, which is responsible for the degradation of cytoplasmic components. During autophagy, HGS is recruited to autophagosomes and may facilitate the fusion of autophagosomes with lysosomes. Studies have shown that HGS interacts with LC3, a key autophagy marker, and that HGS depletion impairs autophagic flux. In the context of esophageal smooth muscle, Hgs deficiency leads to impaired autophagy and accumulation of damaged organelles, contributing to esophageal dysmotility [9]. The interplay between the endosomal and autophagic pathways is complex, and HGS appears to be a key node connecting these two degradative systems.

### 3.6 Protein-Protein Interaction Network

The HGS protein interacts with a wide array of partners, as cataloged in BioGRID and STRING databases. Key interactions include:

- **STAM1/STAM2:** ESCRT-0 complex formation.
- **TSG101:** ESCRT-I recruitment.
- **VPS28:** ESCRT-I component.
- **SARA:** TGF-β signaling.
- **EGFR:** Cargo recognition.
- **Clathrin:** Endosomal coat formation.
- **Ubiquitin:** Cargo recognition.
- **Grb2:** Signaling scaffold.
- **Src:** Tyrosine phosphorylation.
- **p85 (PIK3R1):** PI3K signaling.
- **LC3:** Autophagy.
- **ALIX:** ESCRT-III associated protein.

```mermaid
sequenceDiagram
    participant Ligand as "EGF"
    participant RTK as "EGFR"
    participant PM as "Plasma Membrane"
    participant EE as "Early Endosome"
    participant HGS as "HGS (ESCRT-0)"
    participant STAM as "STAM"
    participant TSG as "TSG101 (ESCRT-I)"
    participant MVB as "Multivesicular Body"
    participant LYS as "Lysosome"
    Ligand->>RTK: Binding
    RTK->>PM: Activation & Dimerization
    PM->>EE: Internalization (Endocytosis)
    EE->>HGS: PI(3)P binding (FYVE)
    HGS->>STAM: Heterodimerization
    RTK->>HGS: Ubiquitinated cargo recognition (UIM)
    HGS->>TSG: PSAP motif interaction
    TSG->>MVB: ESCRT-I recruitment
    MVB->>MVB: ILV formation (ESCRT-II/III)
    MVB->>LYS: Fusion
    LYS->>LYS: Cargo degradation
```

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 The Teetering (tn) Mouse Model

The most well-characterized pathogenic mutation in Hgs is the spontaneous *teetering* (tn) mutation in mice. Positional cloning identified this mutation as a single nucleotide substitution in the Hgs gene, leading to a missense mutation (Ile→Asn) within the FYVE domain. This mutation disrupts the zinc coordination and PI(3)P binding ability of the FYVE domain, abolishing the endosomal localization of HGS. Homozygous tn/tn mice exhibit severe motor and sensory deficits, including ataxia, tremor, and proprioceptive defects, and die within 3–4 weeks of age [8]. Neuropathological examination reveals massive neurodegeneration in the brainstem, spinal cord, and dorsal root ganglia, with accumulation of ubiquitinated protein aggregates and distended endosomes in neurons. This phenotype underscores the critical role of HGS in neuronal survival and function.

### 4.2 Human Mutations and Polymorphisms

While germline mutations in HGS are rare in humans, somatic mutations and copy number alterations are frequently observed in cancer. The COSMIC database catalogs numerous missense, nonsense, and frameshift mutations across various tumor types. The mutation spectrum is not uniform; however, several recurrent hotspots have been identified:

- **R105Q/W:** Located in the VHS domain, this mutation may disrupt STAM binding and ESCRT-0 complex formation.
- **G170R:** Located in the FYVE domain, this mutation is predicted to disrupt PI(3)P binding.
- **P450S:** Located in the PSAP motif, this mutation may impair TSG101 binding and ESCRT-I recruitment.
- **L600P:** Located in the PEST sequence, this mutation may affect protein stability.

The clinical significance of these somatic mutations is context-dependent. In some cancers, HGS acts as a tumor suppressor, and loss-of-function mutations promote oncogenesis. In others, HGS is overexpressed and acts as an oncogene, promoting cell survival and proliferation.

### 4.3 HGS in Restrictive Cardiomyopathy

A landmark study by Li et al. (2022) demonstrated that cardiac-specific deletion of Hgs in mice leads to restrictive cardiomyopathy (RCM) [7]. The Hgs-deficient hearts exhibited increased stiffness, impaired diastolic function, and interstitial fibrosis. Mechanistically, Hgs deficiency disrupted proteostasis in cardiomyocytes, leading to the accumulation of ubiquitinated proteins and activation of the unfolded protein response (UPR). The study also identified a link between Hgs loss and altered TGF-β signaling, which contributed to the fibrotic remodeling. This study established HGS as a critical regulator of cardiac proteostasis and provided a mechanistic link between ESCRT dysfunction and cardiomyopathy.

### 4.4 HGS in Esophageal Motility Disorders

Smooth muscle-specific deletion of Hgs in mice resulted in impaired esophageal motility, characterized by reduced peristalsis and impaired relaxation of the lower esophageal sphincter [9]. The Hgs-deficient smooth muscle cells exhibited disrupted calcium handling and altered expression of contractile proteins. This study highlighted the role of HGS in smooth muscle physiology beyond its canonical role in endosomal sorting.

### 4.5 HGS in Cancer

The role of HGS in cancer is dual and context-dependent.

**Tumor Suppressor Function:** In hepatocellular carcinoma (HCC), HGS expression is frequently downregulated. A kinome siRNA screen identified HGS as a potential synthetic lethal target in liver cancers with oncogenic CTNNB1 mutations [4]. The study found that HGS depletion was selectively toxic to β-catenin-activated cancer cells, suggesting that HGS is a dependency in this context. This finding has therapeutic implications, as targeting HGS could be a strategy for treating CTNNB1-mutant HCC.

**Oncogenic Function:** In high-grade serous ovarian cancer (HGS-OvCa), HGS expression is often elevated. The glucocorticoid receptor (GR) can directly upregulate HGS transcription, and this upregulation is associated with resistance to chemotherapy-induced apoptosis [5, 6]. HGS may promote cell survival by enhancing the degradation of pro-apoptotic factors or by modulating signaling pathways that promote survival. In cervical cancer, HGS has been identified as a stemness-associated hub gene, with elevated expression in cancer stem cells [<a href="#ref-11">11</a>]. Knockdown of HGS in cervical cancer cell lines reduced stemness properties, including sphere formation and drug resistance.

### 4.6 HGS in Neurodegeneration

Beyond the teetering mouse, HGS has been implicated in other neurodegenerative conditions. Altered expression of autophagy-related genes, including HGS, has been observed in multiple sclerosis lesions [<a href="#ref-12">12</a>]. The accumulation of ubiquitinated protein aggregates is a hallmark of many neurodegenerative diseases, and defects in the ESCRT pathway, including HGS dysfunction, may contribute to this pathology.

## 5. Host-Pathogen & Viral Interactions

### 5.1 Chikungunya Virus (CHIKV)

HGS and other ESCRT factors are hijacked by enveloped viruses for various stages of their life cycle. A study by Torii et al. (2020) demonstrated that HGS is recruited to chikungunya virus (CHIKV) replication complexes and is required for efficient viral replication [13]. Using an imaging-based siRNA screen, the authors identified HGS as a host factor that is essential for CHIKV infection. Depletion of HGS significantly reduced viral RNA replication and progeny virus production. The study suggested that HGS may be involved in the formation of viral replication organelles or in the trafficking of viral components to the plasma membrane for budding.

### 5.2 Human Immunodeficiency Virus (HIV)

The ESCRT pathway is critically important for HIV budding. The viral Gag protein recruits ESCRT components, including TSG101 and ALIX, to the plasma membrane to facilitate virus release. While HGS is not directly required for HIV budding, it may play a role in the downregulation of host restriction factors or in the trafficking of viral envelope glycoproteins. The PSAP motif of HGS, which binds TSG101, could compete with the viral p6 domain of Gag for TSG101 binding, potentially modulating viral budding efficiency.

### 5.3 Herpes Simplex Virus (HSV)

HGS may also be involved in the life cycle of herpes simplex virus (HSV). HSV establishes latency in neurons and reactivates upon stress. The virus manipulates host trafficking pathways to evade immune surveillance. HGS-mediated endosomal sorting could be involved in the trafficking of viral glycoproteins or in the downregulation of MHC class I molecules to avoid immune recognition. However, direct evidence for HGS involvement in HSV infection is limited.

### 5.4 SARS-CoV-2

The SARS-CoV-2 virus, which causes COVID-19, relies on host factors for entry and replication. While the primary receptor is ACE2, the virus also exploits the endosomal pathway for cell entry. HGS, as a master regulator of endosomal sorting, could potentially influence the trafficking of the virus or its receptor. However, no direct interaction between HGS and SARS-CoV-2 proteins has been reported. The host-genome similarity analysis of SARS-CoV-2 genomes suggests that the virus has adapted to the human host, but the role of HGS in this adaptation remains speculative [<a href="#ref-1">1</a>].

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 HGS as a Therapeutic Target

Given its central role in multiple signaling pathways and disease processes, HGS is an attractive therapeutic target. However, targeting a protein with such pleiotropic functions requires careful consideration of potential on-target toxicities.

### 6.2 Synthetic Lethality in CTNNB1-Mutant HCC

The identification of HGS as a synthetic lethal target in CTNNB1-mutant HCC opens up a novel therapeutic avenue [4]. The concept is that cancer cells with oncogenic β-catenin signaling are uniquely dependent on HGS for survival. Therefore, inhibiting HGS would selectively kill these cancer cells while sparing normal cells. Several approaches could be employed to target HGS:

- **Small-Molecule Inhibitors:** The FYVE domain's PI(3)P binding pocket could be targeted by small molecules that block membrane recruitment. Similarly, the UIM could be targeted to prevent ubiquitin binding. High-throughput screening campaigns could identify such compounds.
- **Proteolysis-Targeting Chimeras (PROTACs):** PROTACs are bifunctional molecules that recruit an E3 ubiquitin ligase to a target protein, leading to its degradation. A PROTAC targeting HGS could be developed to deplete HGS specifically in cancer cells.
- **RNA Interference (RNAi):** siRNA or shRNA targeting HGS could be delivered using lipid nanoparticles or viral vectors. This approach has shown promise in preclinical studies.

### 6.3 HGS in Chemotherapy Resistance

In HGS-OvCa, HGS expression is associated with chemotherapy resistance [5, 6]. The glucocorticoid receptor (GR) upregulates HGS, and this contributes to resistance to cisplatin and other DNA-damaging agents. Therefore, inhibiting GR signaling or HGS function could sensitize HGS-OvCa cells to chemotherapy. GR antagonists, such as mifepristone, are already in clinical use and could be repurposed for this indication. Combining GR antagonists with standard chemotherapy could be a promising strategy for improving outcomes in HGS-OvCa patients.

### 6.4 PARP Inhibitors and DNA Repair

HGS-OvCa is frequently associated with defects in homologous recombination (HR) repair, making these tumors sensitive to PARP inhibitors (PARPi) [<a href="#ref-2">2</a>]. While HGS is not directly involved in DNA repair, its role in receptor trafficking could influence the response to PARPi. For example, HGS-mediated downregulation of growth factor receptors could affect the tumor microenvironment and the response to therapy. The cumulative defects in DNA repair pathways, including HR, drive the PARPi response, and HGS may modulate this response through indirect mechanisms.

### 6.5 Immunotherapy

HGS may also influence the response to immune checkpoint blockade (ICB) therapy. A tumor-agnostic composite gene expression signature, which may include HGS, has been shown to identify three groups of patients treated with ICB with distinct clinical outcomes [3]. The role of HGS in this signature is not fully understood, but it may reflect the state of the tumor microenvironment and the ability of the immune system to mount an effective anti-tumor response.

### 6.6 Investigational Compounds

Several investigational compounds that modulate the ESCRT pathway are in preclinical development. These include:

- **Vacuolin-1:** A cell-permeable inhibitor of lysosomal trafficking that can affect ESCRT function.
- **U18666A:** A cholesterol transport inhibitor that disrupts endosomal/lysosomal function.
- **Chloroquine:** An anti-malarial drug that inhibits lysosomal acidification and autophagy, which can indirectly affect HGS function.

These compounds are not specific to HGS but can be used as research tools to study the pathway.

## 7. Bioinformatic Resources & Database Accessions

| **Database** | **Identifier** | **URL** |
|---|---|---|
| HGNC | HGS | https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4895 |
| NCBI Gene | 9146 | https://www.ncbi.nlm.nih.gov/gene/9146 |
| Ensembl | ENSG00000169826 | https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000169826 |
| UniProt | O14964 | https://www.uniprot.org/uniprotkb/O14964/entry |
| RCSB PDB | 3F1I (VHS), 1DVP (FYVE) | https://www.rcsb.org/ |
| OMIM | 604375 | https://www.omim.org/entry/604375 |
| ClinVar | HGS | https://www.ncbi.nlm.nih.gov/clinvar/?term=HGS%5Bgene%5D |
| COSMIC | HGS | https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=HGS |
| BioGRID | 109223 | https://thebiogrid.org/109223 |
| STRING | 9606.ENSP00000254852 | https://string-db.org/ |
| Gene Ontology (GO) | GO:0005768 (endosome), GO:0005769 (early endosome), GO:0035091 (PI(3)P binding), GO:0006511 (ubiquitin-dependent protein catabolic process), GO:0007179 (TGF-β receptor signaling pathway) | https://www.ebi.ac.uk/QuickGO/ |
| Mouse Genome Informatics (MGI) | Hgs | https://www.informatics.jax.org/marker/MGI:104671 |

## Related Clinical & Scientific Guides

* [UTY Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/metabolic-pathways/uty-gene-structure-function-pathway)
* [ZBTB42 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/metabolic-pathways/zbtb42-gene-structure-function-pathway)
* [TTLL8 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/metabolic-pathways/ttll8-gene-structure-function-pathway)


## References

<a id="ref-1"></a>[1] "HGS Gene" - (2020). Definitions. URL: https://www.semanticscholar.org/paper/885334c4ff7104c8765a60a8dc3f4f28abe8dc5a

<a id="ref-2"></a>[2] "Court voids HGS gene patent" - M. Francisco (2010). Nature Biotechnology. URL: https://www.semanticscholar.org/paper/346c36d9f3f1200f46b4c55b16e17a67f10d86d1

<a id="ref-6"></a>[6] "Hgs Deficiency Caused Restrictive Cardiomyopathy via Disrupting Proteostasis" - Zhenhua Li, Tianle Wang, Chong Xin, Yao Song, Jing‐rong Kong, Jingping Xu, Qiqi Liu, Y. Teng, N. Hou, Xuan Cheng, Guan Yang, Wenjia Liu, Bin Zhou, You-yi Zhang, Xiao Yang, Jian Wang (2022). International Journal on Biological Sciences. URL: https://www.semanticscholar.org/paper/e182fb4f30805c74a3895925794dba7982e78d9e

<a id="ref-11"></a>[11] "Abstract 6360: A tumor agnostic composite gene expression signature identifies three groups of patients treated with immune checkpoint blockade with distinct clinical outcome" - Mehdi Lamkhioued, Guillaume Robert-Siegwald, Roxane Pommier, Deborah Tricoli, Camille Brodin, V. Attignon, Nicolas Gadot, S. Tabone-Eglinger, Fayette Jerome, A. Swalduz, Isabelle Ray-Coquard, E. Neidhardt, C. Coutzac, L. Verlingue, O. Trédan, J. Blay, Christophe Caux, Alain Viari, Nicolas Poirier, A. Morello, Isabelle Girault, P. Saintigny (2025). Cancer Research. URL: https://www.semanticscholar.org/paper/a032588b93de62bceb55acf2d006c2bbe49942c8

<a id="ref-12"></a>[12] "HUGO and HGS clash over 'utility' of gene sequences in US patent law" - D. Dickson (1995). Nature. URL: https://www.semanticscholar.org/paper/9244cf5995d8fc9affe5c079ae0216c871acc253

<a id="ref-22"></a>[22] "Gene expression profiles of autophagy-related genes in multiple sclerosis." - M. Iğci, M. Baysan, R. Yiğiter, M. Ulaşlı, Sırma Geyik, R. Bayraktar, I. Bozgeyik, Esra Bozgeyi̇k, A. Bayram, E. A. Cakmak (2016). Gene. URL: https://www.semanticscholar.org/paper/c2824f335c07826966f246b56e8ca12000e06da6

<a id="ref-23"></a>[23] "Motor and Sensory Deficits in the teetering Mice Result from Mutation of the ESCRT Component HGS" - Jennifer A. Watson, Bula J. Bhattacharyya, Jada H Vaden, Julie A. Wilson, M. Icyuz, A. D. Howard, Edward Phillips, T. DeSilva, G. Siegal, A. Bean, G. King, S. Phillips, Richard J. Miller, Scott M. Wilson (2015). PLoS Genetics. URL: https://www.semanticscholar.org/paper/b7354408bb3e264b536c03bce70be976a42519c3

<a id="ref-26"></a>[26] "A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1" - Frédéric Canal, Élodie Anthony, Aurianne Lescure, Elaine Del Nery, J. Camonis, F. Perez, B. Ragazzon, C. Perret (2015). BMC Cancer. URL: https://www.semanticscholar.org/paper/9062e1cce97baccafe8ff610137570ba9f5e5949

<a id="ref-28"></a>[28] "Smooth Muscle Hgs Deficiency Leads to Impaired Esophageal Motility" - Jicheng Chen, N. Hou, Chong Zhang, Y. Teng, Xuan Cheng, Zhenhua Li, Jie Ren, J. Zeng, Rui Li, Wei Wang, X. Yang, Yu Lan (2015). International Journal on Biological Sciences. URL: https://www.semanticscholar.org/paper/42ceeebdf6277eeeec16b605cb3172d061031af6

<a id="ref-34"></a>[34] "The discovery of gene mutations making SARS-CoV-2 well adapted for humans: host-genome similarity analysis of 2594 genomes from China, the USA and Europe" - Weitao Sun (2020). Scientific Publication. URL: https://www.semanticscholar.org/paper/1f20c142fe5575553d2df53cbd49b2cf03539659

<a id="ref-45"></a>[45] "Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study." - S. P. Kabekkodu, Alfa Florence Rodrigues, Pratheeksha Hebbar, Samatha Bhat (2026). World Journal of Surgical Oncology. URL: https://www.semanticscholar.org/paper/c2c1fc4e54b3bdef256b9def437d6a9f03681547

<a id="ref-46"></a>[46] "Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA" - Shigeto Miura, T. Takeshita, H. Asao, Y. Kimura, K. Murata, Y. Sasaki, J. Hanai, H. Beppu, T. Tsukazaki, J. Wrana, K. Miyazono, K. Sugamura (2000). Molecular and Cellular Biology. URL: https://www.semanticscholar.org/paper/51b908b20909ec77f146ede16dc033b3fe290abd

<a id="ref-49"></a>[49] "Abstract B32: The role of the glucocorticoid receptor (GR) in inhibiting chemotherapy-induced apoptosis in high-grade serous ovarian carcinoma (HGS-OvCa)" - Erica M Stringer, Maxell N. Skor, Lei Zhao, K. Gwin, E. Lengyel, G. Fleming, S. Conzen (2013). Scientific Publication. URL: https://www